echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > Announcement of the State Food and Drug Administration on Revising the Instructions for Gefitinib Tablets (No. 17 of 2021)

    Announcement of the State Food and Drug Administration on Revising the Instructions for Gefitinib Tablets (No. 17 of 2021)

    • Last Update: 2021-07-08
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    In order to further protect the safety of public medication, the National Medical Products Administration has decided to revise the [Adverse Reactions] and [Precautions] items in the instructions for Gefitinib tablets


    1.


    If the revised content involves the label of a drug, it shall be revised together; the instructions and other content of the label shall be consistent with the original approved content


    Gefitinib tablets manufacturers should conduct in-depth research on the mechanism of new adverse reactions, take effective measures to conduct publicity and training on use and safety issues, and promptly notify drug dealers and users of changes in the content of drug safety in an appropriate manner , Instruct physicians and pharmacists to use drugs rationally


    2.


    3.


    Hereby announce



    Attachment: Requirements for revision of the instructions for Gefitinib tablets




    State Food and Drug Administration


    January 21, 2021




    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.